Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis.

Expert Opinion on Biological Therapy
J CatherJ Christian Cather

Abstract

Introduction: Ixekizumab (IXE), a high affinity humanized monoclonal antibody that selectively targets interleukin-17A, is approved in the United States (US) and the European Union (EU) for pediatric patients with moderate to severe plaque psoriasis. This review summarizes ixekizumab use in the phase 3, randomized, double-blind, placebo-controlled study in pediatric patients with moderate to severe plaque psoriasis and provides some clinical pearls we have learned after using the drug in the pediatric population for the past 3 years.Areas covered: Review of IXORA-PEDS trial data, general literature review pertaining to the systemic treatment of pediatric psoriasis as well as our clinical experience with IXEExpert opinion: IXE is the only IL17 antagonist for pediatric psoriasis and is a welcome addition to our armamentarium.

References

Jan 1, 1974·Dermatologica·E M Farber, M L Nall
Nov 1, 1995·The Journal of Clinical Investigation·D Y LeungM Kotb
Sep 15, 1998·Human Molecular Genetics·J Bhalerao, A M Bowcock
Jul 8, 2000·Pediatric Dermatology·S P Raychaudhuri, J Gross
Mar 10, 2001·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·H J Freeman
Jun 26, 2001·Journal of the American Academy of Dermatology·B KirbyC E Griffiths
Jul 5, 2001·Pediatric Dermatology·A MorrisK Williams
Jun 6, 2003·Journal of the American Academy of Dermatology·David James Najarian, Alice B Gottlieb
May 14, 2005·Skinmed·Shahrad M BehnamJohn Y Koo
Nov 1, 2006·Arthritis and Rheumatism·Matthew L StollPeter A Nigrovic
Jan 18, 2008·The New England Journal of Medicine·Amy S PallerUNKNOWN Etanercept Pediatric Psoriasis Study Group
Nov 10, 2009·Therapeutics and Clinical Risk Management·Nanette B Silverberg
Nov 20, 2009·The British Journal of Dermatology·M AugustinI Schäfer
Sep 14, 2010·Journal of the American Academy of Dermatology·Elaine C SiegfriedGregory Kricorian
Nov 17, 2010·Pediatric Dermatology·Ayhan BilgicEmine Zinnur Kılıç
Apr 29, 2011·The Journal of Pediatrics·Corinna KoebnickJashin J Wu
Jan 17, 2012·Journal of the American Academy of Dermatology·Alexa B KimballParvez M Mulani
Apr 12, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ragna Hlin ThorleifsdottirHelgi Valdimarsson
Aug 18, 2012·International Journal of Rheumatic Diseases·Laura NiccoliFabrizio Cantini
May 17, 2013·American Journal of Clinical Dermatology·Kara N Shah
Sep 11, 2013·Pediatric Dermatology·Ari M GoldminzAlice B Gottlieb
Nov 12, 2013·Trends in Molecular Medicine·Robert J CommonsNigel Curtis
Jan 15, 2014·World Journal of Gastroenterology : WJG·Hugh James Freeman
Apr 15, 2014·Adolescent Health, Medicine and Therapeutics·Christina FotiadouDemetrios Ioannides
Jul 16, 2014·Journal of Pediatric Gastroenterology and Nutrition·Firas RinawiRaanan Shamir
Oct 14, 2014·World Journal of Gastroenterology : WJG·Marco Gasparetto, Graziella Guariso
Jan 19, 2016·Journal of the American Academy of Dermatology·Amy S PallerRichard G Langley
Feb 9, 2016·Journal of Pediatric Gastroenterology and Nutrition·Casey BishopGhassan Wahbeh
Mar 8, 2016·Journal of the American Academy of Dermatology·Ellen S HaddockWynnis L Tom
Mar 13, 2016·Annales de dermatologie et de vénéréologie·J BonigenUNKNOWN Groupe de recherche de la Société française de dermatologie pédiatrique
Sep 17, 2016·Journal of Clinical Gastroenterology·Domenico Corica, Claudio Romano
Sep 23, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Hana ManceauKatell Peoc'h
Oct 21, 2016·Alcoholism, Clinical and Experimental Research·Subhajit ChakravortyKirk J Brower
Nov 21, 2016·Journal of the American Academy of Dermatology·Megha M TollefsonDavid T Eton
Jan 28, 2017·Inflammatory Bowel Diseases·William A FaubionAndreas Lazar
Feb 6, 2017·The Journal of Rheumatology·Devy ZismanUNKNOWN CARRA Legacy Registry Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.